Home » Inspire Pharmaceuticals Launches AzaSite in the United States for Ocular Infections
Inspire Pharmaceuticals Launches AzaSite in the United States for Ocular Infections
Inspire Pharmaceuticals, Inc. announced the U.S. launch and commercial availability of AzaSite (azithromycin ophthalmic solution) 1 percent for the treatment of bacterial conjunctivitis.
Inspire Pharmaceuticals Inc.
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May